Supernus Pharmaceuticals, Inc. (SUPN) Free Cash Flow
Supernus Pharmaceuticals, Inc. (SUPN) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2019-12-31 | $140.39M |
| 2020-12-31 | $138.40M |
| 2021-12-31 | $125.08M |
| 2022-12-31 | $116.41M |
| 2023-12-31 | $110.53M |
| 2024-12-31 | $7.00M |
| 2025-03-31 | $68.00M |
| 2025-09-30 | $153.00M |
| 2025-12-31 | -$93.00M |
| 2026-03-31 | -$30.00M |
How SUPN compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| HRTX | Heron Therapeutics Inc. | -$27.91M |
| DMAC | DiaMedica Therapeutics Inc. | -$29.10M |
| RFL | Rafael Holdings Inc. Class B | -$29.99M |
| VERU | Veru Inc. | -$30.04M |
| ALDX | Aldeyra Therapeutics Inc. | -$33.35M |
These are five companies in the same sector as SUPN with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Supernus Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("SUPN", 2026, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SUPN | $28.93 | -0.94% | 0.09M |
| 3 | ||||
| 4 | ||||
| 5 |